Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × Barrett Esophagus × Ursodeoxycholic Acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 1 Barrett Esophagus 1

Interventions

Specimen Handling 2 Endoscopy, Digestive System 2 Endoscopy 2 Biopsy 2 Aspirin 2 polyphenon E 1 obeticholic acid 1 Ursodeoxycholic Acid 1 Radiofrequency Ablation 1 Metformin 1 Itraconazole 1 Genetic Linkage 1 Gastroscopy 1 Esomeprazole 1 Erlotinib Hydrochloride 1 Comparative Genomic Hybridization 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01097304 2017-12-19

Ursodiol in Treating Patients With Barrett Esophagus and Low-Grade Dysplasia

National Cancer Institute (NCI)

Phase 2 Completed

36 enrolled 10 charts

Gastrointestinal

Barrett Esophagus, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡